Preventative HIV vaccine candidate triggers desired immune responses in humans and monkeys, and protects monkeys from infection

July 10, 2018

Promising findings lead to initiation of a clinical efficacy trial in southern Africa

BOSTON - More than three decades after the identification of the human immunodeficiency virus (HIV), scientists are still working to develop a preventative vaccine that could finally put an end to the epidemic for which there are nearly two million new infections each year. 

Read from the source